Noninvasive collection of cell and region specific miRNA from heterogeneous tissues.
Award amount
$190,311Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NEUROINDX
- Proposal award date
- 2016-02-01
- Contract end date
- 2018-01-31
- UEI
- XS6TCKK96DR6
- Solicitation number
- PA14-071
- Topic code
- 200
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- On-Chip Assay for Identifying Candidate Microtubule Binding Drugs to Treat ADRDs
- High throughput single cell linear displacement adhesion assay
- Automated Platform for Fixed Tissue Microdissection
- Automated Platform for Fixed Tissue Microdissection
- Low-cost microdissection system for live brain cell collection (CTAS-Live)
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
- Next-Gen Oral Therapeutics for Type 2 Diabetes
- Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism
- Development of novel therapeutics for obesity and type 2 diabetes
- Metrifonate local application for DFU treatment
Research funding history
11 SBIR/STTR records share this UEI (2007–2024). Reported award amounts total $7,493,210. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services